A Globes news report indicates that Xenia Venture Capital Ltd has announced $10 million in financing for Ninox Medical, a company developing a device for the treatment of obstructive sleep apnea.
“We’re glad about the completion of a respectable financing round from top-tier investors in a promising portfolio company, which promises to accelerate Ninox’s entry into the OSA market with an innovate product. We regard this substantial round as testimony from the investors as to Ninox’s great potential, and believe that Ninox, like other portfolio companies, will see significant progress already in 2015,” said Xenia CEO Anat Segal.
